139 related articles for article (PubMed ID: 12548077)
1. Differences between angiotensin-converting enzyme inhibition and angiotensin II-AT1 antagonism on angiotensin-mediated responses in human internal mammary arteries.
Voors AA; Oosterga M; Buikema H; Mariani M; Grandjean JG; van Gilst WH
J Cardiovasc Pharmacol; 2003 Feb; 41(2):178-84. PubMed ID: 12548077
[TBL] [Abstract][Full Text] [Related]
2. Functional evidence for a role of vascular chymase in the production of angiotensin II in isolated human arteries.
Richard V; Hurel-Merle S; Scalbert E; Ferry G; Lallemand F; Bessou JP; Thuillez C
Circulation; 2001 Aug; 104(7):750-2. PubMed ID: 11502696
[TBL] [Abstract][Full Text] [Related]
3. Dual pathway for angiotensin II formation in human internal mammary arteries.
Voors AA; Pinto YM; Buikema H; Urata H; Oosterga M; Rooks G; Grandjean JG; Ganten D; van Gilst WH
Br J Pharmacol; 1998 Nov; 125(5):1028-32. PubMed ID: 9846641
[TBL] [Abstract][Full Text] [Related]
4. Vasoconstriction by in situ formed angiotensin II: role of ACE and chymase.
MaassenVanDenBrink A; de Vries R; Saxena PR; Schalekamp MA; Danser AH
Cardiovasc Res; 1999 Nov; 44(2):407-15. PubMed ID: 10690317
[TBL] [Abstract][Full Text] [Related]
5. Vasoconstrictor effect of the angiotensin-converting enzyme-resistant, chymase-specific substrate [Pro(11)(D)-Ala(12)] angiotensin I in human dorsal hand veins: in vivo demonstration of non-ace production of angiotensin II in humans.
McDonald JE; Padmanabhan N; Petrie MC; Hillier C; Connell JM; McMurray JJ
Circulation; 2001 Oct; 104(15):1805-8. PubMed ID: 11591618
[TBL] [Abstract][Full Text] [Related]
6. Bradykinin potentiation by angiotensin-(1-7) and ACE inhibitors correlates with ACE C- and N-domain blockade.
Tom B; de Vries R; Saxena PR; Danser AH
Hypertension; 2001 Jul; 38(1):95-9. PubMed ID: 11463767
[TBL] [Abstract][Full Text] [Related]
7. Effects of angiotensin I and angiotensin II in blood vessels: greater influence of converting enzyme activity in the rabbit basilar artery.
Zerrouk A; Auguet M; Delaflotte S; Chabrier PE
Naunyn Schmiedebergs Arch Pharmacol; 1996 Oct; 354(4):466-73. PubMed ID: 8897450
[TBL] [Abstract][Full Text] [Related]
8. Additive effects of combined angiotensin-converting enzyme inhibition and angiotensin II antagonism on blood pressure and renin release in sodium-depleted normotensives.
Azizi M; Chatellier G; Guyene TT; Murieta-Geoffroy D; Ménard J
Circulation; 1995 Aug; 92(4):825-34. PubMed ID: 7641363
[TBL] [Abstract][Full Text] [Related]
9. Maximally recommended doses of angiotensin-converting enzyme (ACE) inhibitors do not completely prevent ACE-mediated formation of angiotensin II in chronic heart failure.
Jorde UP; Ennezat PV; Lisker J; Suryadevara V; Infeld J; Cukon S; Hammer A; Sonnenblick EH; Le Jemtel TH
Circulation; 2000 Feb; 101(8):844-6. PubMed ID: 10694521
[TBL] [Abstract][Full Text] [Related]
10. Effect of angiotensin-converting enzyme two-week inhibition on renal angiotensin II receptors and renal vascular reactivity in SHR.
Haddad G; Garcia R
J Mol Cell Cardiol; 1997 Feb; 29(2):813-22. PubMed ID: 9140837
[TBL] [Abstract][Full Text] [Related]
11. Angiotensin I is converted to angiotensin II by a serine protease in human detrusor smooth muscle.
Lindberg BF; Nilsson LG; Hedlund H; Stahl M; Andersson KE
Am J Physiol; 1994 Jun; 266(6 Pt 2):R1861-7. PubMed ID: 8024040
[TBL] [Abstract][Full Text] [Related]
12. Functional evidence for alternative ANG II-forming pathways in hamster cardiovascular system.
Nishimura H; Buikema H; Baltatu O; Ganten D; Urata H
Am J Physiol; 1998 Oct; 275(4):H1307-12. PubMed ID: 9746480
[TBL] [Abstract][Full Text] [Related]
13. The Interplay between the Renin Angiotensin System and Pacing Postconditioning Induced Cardiac Protection.
Babiker F; Al-Jarallah A; Joseph S
PLoS One; 2016; 11(11):e0165777. PubMed ID: 27814397
[TBL] [Abstract][Full Text] [Related]
14. Differential action of angiotensin II and activity of angiotensin-converting enzyme in human bypass grafts.
Borland JA; Chester AH; Crabbe S; Parkerson JB; Catravas JD; Yacoub MH
J Thorac Cardiovasc Surg; 1998 Aug; 116(2):206-12. PubMed ID: 9699571
[TBL] [Abstract][Full Text] [Related]
15. Effect of angiotensin converting enzyme inhibitors on the vasoconstrictor action of angiotensin I on isolated rat kidney.
Schmidt M; Giesen-Crouse EM; Krieger JP; Welsch C; Imbs JL
J Cardiovasc Pharmacol; 1986; 8 Suppl 10():S100-5. PubMed ID: 2438482
[TBL] [Abstract][Full Text] [Related]
16. ACE-versus chymase-dependent angiotensin II generation in human coronary arteries: a matter of efficiency?
Tom B; Garrelds IM; Scalbert E; Stegmann AP; Boomsma F; Saxena PR; Danser AH
Arterioscler Thromb Vasc Biol; 2003 Feb; 23(2):251-6. PubMed ID: 12588767
[TBL] [Abstract][Full Text] [Related]
17. Angiotensin-converting enzyme-independent contraction to angiotensin I in human resistance arteries.
Padmanabhan N; Jardine AG; McGrath JC; Connell JM
Circulation; 1999 Jun; 99(22):2914-20. PubMed ID: 10359736
[TBL] [Abstract][Full Text] [Related]
18. ACE and non-ACE mediated effect of angiotensin I on intracellular calcium mobilization in rat glomerular arterioles.
Marchetti J; Helou CM; Chollet C; Rajerison R; Alhenc-Gelas F
Am J Physiol Heart Circ Physiol; 2003 Jun; 284(6):H1933-41. PubMed ID: 12586636
[TBL] [Abstract][Full Text] [Related]
19. Selective angiotensin-converting enzyme C-domain inhibition is sufficient to prevent angiotensin I-induced vasoconstriction.
van Esch JH; Tom B; Dive V; Batenburg WW; Georgiadis D; Yiotakis A; van Gool JM; de Bruijn RJ; de Vries R; Danser AH
Hypertension; 2005 Jan; 45(1):120-5. PubMed ID: 15583077
[TBL] [Abstract][Full Text] [Related]
20. Effect of the AT1-receptor antagonists losartan, irbesartan, and telmisartan on angiotensin II-induced facilitation of sympathetic neurotransmission in the rat mesenteric artery.
Balt JC; Mathy MJ; Nap A; Pfaffendorf M; van Zwieten PA
J Cardiovasc Pharmacol; 2001 Jul; 38(1):141-8. PubMed ID: 11444497
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
